Clinical Blinding Solutions
Our commitment to excellence empowers you to conduct clinical trials with confidence, knowing that your data is protected and your results are trustworthy. By implementing our Clinical Blinding Solutions, you can eliminate bias, protect the integrity of your study, and ensure that your results are both scientifically valid and ethically sound.
Clinical Multi-layer Labels
Optimize your clinical trial operations with our state-of-the-art Clinical Multi-Layer Labels, designed to accommodate detailed information on a compact, durable surface. These labels are perfect for conveying critical data, ensuring regulatory compliance and enhancing the overall efficiency of your clinical research processes.
Clinical Booklet Labels
Streamline your clinical trial processes with our innovative Clinical Booklet Labels, specifically
designed to meet the complex needs of global clinical research. These Booklet Labels provide
a practical and efficient solution for conveying extensive information in a reader-friendly format,
with up to 113 pages on a compact surface, ensuring compliance and enhancing the organization
of your clinical trials.
Pharmapack 2025
Are you ready to step into the future of packaging and labeling solutions? Look no further – we’re excited to invite you to an exclusive event that promises to reshape the way you think about product presentation and patient engagement. Prepare to be amazed by cutting-edge technology, innovative solutions, and a vision that’s set to transform the pre-filled and injectable market.
GS1 Connect 2024
Join us on June 4-6th, 2024, Orlando, Florida at the Orlando World Center Marriott for an excellent show!
CCL Healthcare Expands Montreal Facility: A Leap Towards Innovation and Growth
CCL Healthcare is proud to announce the expansion of its facility in Montreal, Canada. This expansion serves as a significant milestone in our 40-year history of operation in the city, with the most recent 20 years under the ownership of CCL Industries. Pierre Dery, the owner prior to CCL, expressed his enthusiasm for this development, underscoring the businesses legacy.